Australian & New Zealand Thyroid Cancer Registry
This involved Bianka D’Souza, a Master of Public Health (Research) student completing a qualitative research study, which lead to the award of her Master’s thesis with co-supervision from A/Prof Anthony Glover. The ANZTCR has now recruited more than 2,000 patients, and from 2022 the registry will present the first set of quality performance indicators, for which RNSH will be a major contributor. The performance indicators will provide insight into thyroid cancer care across greater Australia.
Throughout 2021, the RNSH Endocrine Surgery Department continued to provide support and data for the Australia and New Zealand Thyroid Cancer Registry (ANZTCR). The ANZTCR is based at Monash University and aims to provide benchmarks for thyroid cancer care. The RNSH department continued to be the highest contributing department to the registry, which now includes over 40 hospitals. Endocrine Data Manager, Dr Ahmad Aniss, streamlined the delivery of data from the RNSH Endocrine Surgery Database, allowing the ANZTCR to grow and develop within the existing workflows of the department. This led to further research projects and collaboration between Australian New Zealand Endocrine Surgeons (ANZES) and ANZTCR. One project of note involved an investigation of patient experiences of treatment delays due to the COVID-19 pandemic.
ANZES Members
National Endocrine Society & Registry In 2021, the Endocrine Surgery Australian New Zealand Endocrine Surgeons
cancer care. In an international project undertaken in collaboration with the Sydney School of Public Health, clinicians reported that while patients with thyroid cancer experienced delays to treatment, these were generally for lower risk patients and affected presentations overall, rather than clinically urgent presentations. This project led to a publication with the ANZ Journal of Surgery, and a project to further understand the experiences of patients who had treatment delays due to the pandemic was launched with the ANZ Thyroid Cancer Registry.
Other achievements from ANZES in 2021 included: • Publication of the inaugural ANZ parathyroid treatment guidelines, for which
Under the leadership of Clin. A/Prof Mark Sywak and Professor Julie Miller (President), the society continued to grow in membership throughout 2021.
Department at RNSH continued to make a major contribution to the Australian New Zealand Endocrine Surgeons (ANZES) Society. A/ Prof Mark Sywak served as the Public Officer and A/ Prof Anthony Glover served as the Scientific and Research Officer with the ANZES Executive. One of the ANZES 2021 initiatives was to understand the impact of the COVID-19 pandemic on thyroid
Clin. A/Prof Mark Sywak, A/Prof Anthony Glover, and Professor Stan Sidhu provided expert advice. Continuation of the ANZES Endocrine Surgery Fellowship training scheme, which is currently being led by Associate Professor Justin Gundara, a former PhD student and trainee with the department and the Kolling Institute.
•
8
9
Endocrine Surgery Annual Report 2021
Endocrine Surgery Annual Report 2021
Made with FlippingBook - professional solution for displaying marketing and sales documents online